Learn More
Apexbio Technology LLC CD 3254 196961-43-0 10mg

Supplier: Apexbio Technology LLC B735210
CD 3254 (CAS 196961-43-0) is a selective agonist targeting the retinoid X receptor-alpha (RXR ) a member of the NR2B nuclear receptor family It is designed to activate RXR thereby influencing transcriptional regulation involved in lipid metabolism glucose homeostasis and immune responses CD 3254 exerts its biological activity primarily through ligand-induced activation of RXR which can form homodimers or heterodimers with other nuclear receptors such as RAR PPAR and LXR Based on these pharmacological properties CD 3254 holds research potential in RXR-mediated signaling pathways and possible therapeutic applications in skin conditions such as cutaneous T-cell lymphoma (CTCL)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.